TAAR1: What Is the Role of TAAR1 Agonism for the Treatment of Schizophrenia?
Вставка
- Опубліковано 30 вер 2024
- Dr. Jonathan M. Meyer of UC San Diego talks about TAAR1 agonism used in schizophrenia treatment.
This video is part of a larger CE/CME Certified program entitled: Schizophrenia: A Promising Treatment Era Dawns. You can receive free CME credit, view this video, and download slides from the presentation at www.mededonthe...
Can they try again phase 3 clinical trials for ulotaront? Seems so promising.
What about the negative symptoms of schizophrenia
Not only did Ulotaront not separate from placebo in phase 3, but asenapine also acts as a TAAR1 agonist already!
wonderful presentation, thank you !!
When will this medicine come in market?